2025 Annual Shareholder Meeting and Director Nominations

MEETING
Tue, Jun 24 2025 08:30 am

24 June 2025

2025 Annual Shareholder Meeting and Director Nominations

BLIS Technologies Limited’s 2025 Annual Shareholder Meeting will be held at Tūhura Otago Museum, The Hutton Theatre, 419 Great King Street, Dunedin on Thursday, 21 August 2025 commencing at 11.00 am. This meeting will also be hosted virtually.

Further details regarding the meeting will be provided in the Notice of Meeting which will be sent to all shareholders at least 20 working days prior to the meeting.

The closing date for nominations by shareholders of directors to be considered for election at the Annual Shareholder Meeting is Tuesday, 8 July 2025.

Nominations may be made by a shareholder entitled to attend and vote at the Annual Shareholder Meeting and must be accompanied by a consent in writing by a nominated person.

Nominations should be addressed by mail or email to:

Richard Wingham
Chief Financial Officer
Blis Technologies Limited
PO Box 2208
Dunedin 9044

Email: [email protected]

Ends

For further information, please contact:

Richard Wingham
Chief Financial Officer
+64 21 284 0446

About BLIS Technologies Ltd

Delivering proven health benefits through evidence-based, advanced probiotics BLIS Technologies is an NZX-listed manufacturer of advanced probiotic strains that go beyond the gut. Combining innovation with evidence-based research and the highest quality production controls enables the delivery of probiotic solutions for specific health targets including throat health, halitosis (bad breath), immune support, teeth and gum health and skin health. BLIS® products are sold throughout New Zealand and in Asia, Europe and the USA. More information about BLIS Technologies Ltd can be found at www.blis.co.nz.

Website: www.blis.co.nz
Instagram: @blisprobiotics #blisk12 #blism18 #blisq24
Facebook: @BLISProbiotics


Announcement PDF


Markets News

FMA to focus on private market offers
Markets

FMA to focus on private market offers

The FMA is worried about unsophisticated investors taking the bait.

Markets

Xero splashes $4.1b for 'step-change' US acquisition

Buying Melio gives Xero a leg-up in the crucial US SME market.

Xero splashes $4.1b for 'step-change' US acquisition
Infrastructure

Chorus broadband expansion makes priority list

Chorus claims $17 billion NZ Inc gain for a $3b spend.

Chorus broadband expansion makes priority list